Detection and Treatment of Pregnancy Complications Comprising Determining Sialyl Lewis Antigens and Administering hCG

    公开(公告)号:US20200166527A1

    公开(公告)日:2020-05-28

    申请号:US16777444

    申请日:2020-01-30

    IPC分类号: G01N33/76 A61K38/24 G01N33/68

    摘要: Disclosed herein is a method of identifying and/or addressing incipient preeclampsia in a patient-subject by the steps of (a) performing a bioassay to determine the level of at least one sialyl Lewis antigen in a said patient-subject at about 25 weeks of pregnancy or earlier; (b) performing a bioassay to determine the level of at least one sialyl Lewis antigen in a pregnant non-preeclampsia one or more subjects at about 30 weeks of pregnancy or later, wherein said at least one sialyl Lewis antigen assay is for a sialyl Lewis antigen assayed in step (a) is and if more than one subject is assayed, averaging said results; and (c) managing said patient-subject for preeclampsia, if said level of at least one sialyl Lewis antigen of step (a) is at or greater than about 20% above the level of such silalyl Lewis antigen assayed in step (b).

    Treatment of disease using inter-alpha inhibitor proteins
    3.
    发明授权
    Treatment of disease using inter-alpha inhibitor proteins 有权
    使用α间期抑制蛋白治疗疾病

    公开(公告)号:US09572872B2

    公开(公告)日:2017-02-21

    申请号:US14426832

    申请日:2013-09-09

    IPC分类号: A61K38/00 A61K38/57

    摘要: The invention relates to methods of treatment of medical conditions (e.g., diseases and injuries) in a mammal (e.g., a human), such as hypoxia/ischemia, burns, and viral infections (e.g., influenza, West Nile virus, and Dengue fever), in adults and in children (e.g., neonates) by administering a composition that includes an IAIP.

    摘要翻译: 本发明涉及治疗哺乳动物(例如人)中的医学病症(例如疾病和损伤)的方法,例如缺氧/缺血,烧伤和病毒感染(例如,流感,西尼罗病毒和登革热 ),在成人和儿童(如新生儿)中,通过施用包含IAIP的组合物。

    TREATMENT OF DISEASE USING INTER-ALPHA INHIBITOR PROTEINS
    6.
    发明申请
    TREATMENT OF DISEASE USING INTER-ALPHA INHIBITOR PROTEINS 有权
    用ALPHA抑制蛋白治疗疾病

    公开(公告)号:US20150238578A1

    公开(公告)日:2015-08-27

    申请号:US14426832

    申请日:2013-09-09

    IPC分类号: A61K38/57

    摘要: The invention relates to methods of treatment of medical conditions (e.g., diseases and injuries) in a mammal (e.g., a human), such as hypoxia/ischemia, burns, and viral infections (e.g., influenza, West Nile virus, and Dengue fever), in adults and in children (e.g., neonates) by administering a composition that includes an IAIP.

    摘要翻译: 本发明涉及治疗哺乳动物(例如人)中的医学病症(例如疾病和损伤)的方法,例如缺氧/缺血,烧伤和病毒感染(例如,流感,西尼罗河病毒和登革热 ),在成人和儿童(如新生儿)中,通过施用包含IAIP的组合物。

    Detection and Treatment of Pregnancy Complications

    公开(公告)号:US20180321262A1

    公开(公告)日:2018-11-08

    申请号:US15889261

    申请日:2018-02-06

    IPC分类号: G01N33/76 A61K38/24 G01N33/68

    摘要: Disclosed herein is a method of identifying and/or addressing incipient preeclampsia in a patient-subject by the steps of (a) performing a bioassay to determine the level of at least one sialyl Lewis antigen in a said patient-subject at about 25 weeks of pregnancy or earlier; (b) performing a bioassay to determine the level of at least one sialyl Lewis antigen in a pregnant non-preeclampsia one or more subjects at about 30 weeks of pregnancy or later, wherein said at least one sialyl Lewis antigen assay is for a sialyl Lewis antigen assayed in step (a) is and if more than one subject is assayed, averaging said results; and (c) managing said patient-subject for preeclampsia, if said level of at least one sialyl Lewis antigen of step (a) is at or greater than about 20% above the level of such silalyl Lewis antigen assayed in step (b).

    METHOD FOR THE DETECTION AND TREATMENT OF PROTEINOPATHIES

    公开(公告)号:US20240077500A1

    公开(公告)日:2024-03-07

    申请号:US18260661

    申请日:2022-01-13

    发明人: Surendra Sharma

    IPC分类号: G01N33/68 G01N33/50

    摘要: The present disclosure relates in part to a blood-based method for the detection of a proteinopathy in a subject including, but not limited to, Alzheimer's disease (AD), mild cognitive impairment (MCI), and preeclampsia (PE), utilizing autophagy-deficient trophoblast (ADT) cells to sequester protein aggregates from the serum of said subject, and permit detection thereof. The present disclosure further relates to methods of treating, preventing, and/or ameliorating a proteinopathy in a subject by the administration of trehalose, a salt, solvate, stereoisomer, derivative, prodrug and or any mixture thereof.